TCMBANKIN002618 |
malloprenyl linolenate |
|
C63H102O2 |
|
CCC=CCC=CCC=CCCCCCCCC(=O)OCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C |
TCMBANKIN008481 |
Ruvoside |
3-[(5R,10R,14S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; ruvoside; AC1O3DXD |
C30H46O9 |
550.68 |
[HH].CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)CO)O)OC)O |
TCMBANKIN012901 |
mallotochromene |
|
C24H26O8 |
442.5 g/mol |
CC1=C(C(=C(C(=C1OC)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C)O)O)C(=O)C)O |
TCMBANKIN016152 |
malloprenol |
|
C45H74O |
|
|
TCMBANKIN017018 |
buxamine e |
|
C26H44N2 |
384.6 g/mol |
CC(C1CCC2(C1(CC=C3C2CCC4C(=C3)CCC(C4(C)C)N(C)C)C)C)N |
TCMBANKIN018559 |
mallotophenone |
|
C21H24O8 |
404.4 g/mol |
CC1=C(C(=C(C(=C1OC)CC2=C(C(=C(C(=C2O)C(=O)C)O)C)OC)O)C(=O)C)O |
TCMBANKIN020209 |
butyrylmallotojaponin |
|
C27H34O8 |
486.6 g/mol |
CCCCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(=C(C(=C2O)C(=O)C)O)C)OC)O)CC=C(C)C)O |
TCMBANKIN023616 |
Purine |
purine; PURINE-RING; CHEBI:17258; 6H-Imidazo(4,5-d)pyrimidine; 9H-Purine; 3,5,7-TRIAZAINDOLE; AC-907/25014050; X 128; AIDS023033; 120-73-0; EINECS 204-421-2; C00465; P55805_ALDRICH; C15587; 6H-Imidazo[4,5-d]pyrimidine; 82580_FLUKA; SBB004288; InChI=1/C5H4N4/c1-4-5(8-2-6-1)9-3-7-4/h1-3H,(H,6,7,8,9; ZINC00152268; 7H-Imidazo[4,5-d]pyrimidine; CHEBI:35589; .beta.-Purine; AI3-50208; 3H-purine; AIDS-023033; NSC 753; 1H-Purine; P1655_SIGMA; Imidazo[4,5-d]pyrimidine; 7H-Purine; NSC753; CHEBI:35586; 1H-Purine (9CI); 9H-Purine (VAN); Imidazo(4,5-d)pyrimidine; CHEBI:35588; Isopurine; beta-Purine; 7H-Imidazo(4,5-d)pyrimidine; WLN: T56 BM DN FN HNJ |
C5H4N4 |
120.11 |
C1=C2C(=NC=N1)N=CN2 |
TCMBANKIN029966 |
mallotusinic acid |
mallotusinicacid |
C48H32O32 |
1120.75 |
C1C2C3C(C(C(O2)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C6=C5C7C(=CC(=O)C(C7(O)O)(O6)O)C(=O)O3)O)O)OC(=O)C8=CC(=C(C(=C8C9=C(C(=C(C=C9C(=O)O1)O)O)O)O)O)OC1=C(C(=C(C=C1C(=O)O)O)O)O |
TCMBANKIN040222 |
Mallotojaponin |
|
|
444.5 g/mol |
|
TCMBANKIN042474 |
Isobutyrylmallotochromene |
1-[6-[(3-acetyl-2,4-dihydroxy-6-methoxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethylchromen-8-yl]-2-methylpropan-1-one; 1-[6-(3-acetyl-2,4-dihydroxy-6-methoxy-5-methyl-benzyl)-5,7-dihydroxy-2,2-dimethyl-chromen-8-yl]-2-methyl-propan-1-one; C09009; isobutyrylmallotochromene; 1-[6-[(3-acetyl-2,4-dihydroxy-6-methoxy-5-methyl-phenyl)methyl]-5,7-dihydroxy-2,2-dimethyl-chromen-8-yl]-2-methyl-propan-1-one; Isobutyrylmaeelotochromene; 116964-16-0; 1-[6-[(3-acetyl-2,4-dihydroxy-6-methoxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethyl-8-chromenyl]-2-methylpropan-1-one; 1-[6-[(3-ethanoyl-2,4-dihydroxy-6-methoxy-5-methyl-phenyl)methyl]-5,7-dihydroxy-2,2-dimethyl-chromen-8-yl]-2-methyl-propan-1-one |
C26H30O8 |
470.51 |
CC1=C(C(=C(C(=C1OC)CC2=C(C(=C3C(=C2O)C=CC(O3)(C)C)C(=O)C(C)C)O)O)C(=O)C)O |
TCMBANKIN042722 |
isomallotochromene |
|
C24H26O8 |
442.5 g/mol |
CC1=C(C(=C(C(=C1OC)CC2=C3C(=C(C(=C2O)C(=O)C)O)C=CC(O3)(C)C)O)C(=O)C)O |
TCMBANKIN043680 |
isomallotochromanol |
|
C24H28O9 |
460.5 g/mol |
CC1=C(C(=C(C(=C1OC)CC2=C3C(=C(C(=C2O)C(=O)C)O)CC(C(O3)(C)C)O)O)C(=O)C)O |
TCMBANKIN043849 |
Geraniin |
AKOS015965424; CHEBI:5328; AC1MHDT3; 60976-49-0; BG01794303; ST24046002; Geraniiin; .beta.-D-Glucopyranose, cyclic 2.fwdarw.7:4.fwdarw.5-(3,6-dihydro-2,9,10,11,11-pentahydroxy-3-oxo-2,6-methano-2H-1-benzoxocin-5,7-dicarboxylate)cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), stereoisomer; BDBM50242278; BC216245; Q-100702; ZINC169289506; [undecahydroxy(pentaoxo)[?]yl] 3,4,5-trihydroxybenzoate; AIDS-048857; AC-8425; C10230; D0C6QS; 4CN-2802; .beta.-D-Glucopyranose, cyclic 2.fwdarw.7:4.fwdarw.5-(3,6-dihydro-2,9,10,11,11-pentahydroxy-3-oxo-2,6-methano-2H-1-benzoxocin-5,7-dicarboxylate) cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate), stereo; Geraniin; AIDS048857; CHEMBL506069; (1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-UNDECAHYDROXY-2,5,10,23,31-PENTAOXO-6,9,24,27,30,40-HEXAOXAOCTACYCLO[34.3.1.0?,(3)?.0?,(2)?.0?,(2)?.0(1)(1),(1)?.0(1)?,(2)(2).0(3)(2),(3)?]TETRACONTA-3,11(16),12,14,17(22),18,20,32,34,36-DECAEN-28-YL 3,4,5-TRIHYDROXYBENZOATE; JQQBXPCJFAKSPG-SVYIMCMUSA-N; (1R,7R,8S,26R,28S,29R,38R)-1,13,14,15,18,19,20,34,35,39,39-UNDECAHYDROXY-2,5,10,23,31-PENTAOXO-6,9,24,27,30,40-HEXAOXAOCTACYCLO[34.3.1.0?,(3)?.0?,(2)?.0?,(2)?.0(1)(1),(1)?.0(1)?,(2)(2).0(3)(2),(3)?]TETRACONTA-3,11(16),12,14,17,19,21,32(37),33,35-DECAEN-28-YL 3,4,5-TRIHYDROXYBENZOATE; geraniin |
C41H28O27 |
953 |
[C@]12([H])[C@]3([H])[C@]([H])(OC(=O)c(c([H])c(O[H])c(O[H])c4O[H])c4c(c(O[H])c(O[H])c(O[H])c5[H])c5C(=O)OC1([H])[H])[C@@]([H])(OC(=O)c(c([H])c(O[H])c6O[H])c(c6O7)[C@@]([H])(C(C(=O)O3)=C([H])C8=O)[C@@]
7(O[H])C8(O[H])O[H])[C@]([H])(OC(=O)c9c([H])c(O[H])c(O[H])c(O[H])c9[H])O2 |
TCMBANKIN044958 |
3'-isobutyryloxy-o-acetyl-2',3'-dihyero-oroselol |
|
C20H24O7 |
376.4 |
|
TCMBANKIN045819 |
Butyrylma Ilotochromene |
|
|
|
|
TCMBANKIN057922 |
malonicacid |
malonic acid; MLI; AI3-15375; C00383; DICARBOXYLIC ACID C3; InChI=1/C3H4O4/c4-2(5)1-3(6)7/h1H2,(H,4,5)(H,6,7; Dicarboxylate; PROPANEDIOIC ACID MALONIC ACID; AIDS-017691; malonic acid; 1,3-Propanedioic acid; Malonic acid (8CI); propanedioic acid; Carboxyacetic acid; Methanedicarboxylic acid; C02028; METAHNEDICARBOXYLIC ACID; Dicarboxymethane; Malonate standard for IC; C04025; alpha,omega-Dicarboxylic acid; 141-82-2; AIDS017691; MLA; NSC8124; PROPANEDIOLIC ACID; Usaf ek-695; 4-02-00-01874 (Beilstein Handbook Reference); HOOC-CH2-COOH; ST5213926; 49323_FLUKA; Propanedioic acid (9CI); M1296_SIAL; 211863-95-5; nchembio.2007.22-comp12; WLN: QV1VQ; CHEBI:30794; Kyselina malonova [Czech]; Dicarboxylic acid; NSC 8124; BRN 1751370; EINECS 205-503-0; LMFA01170041; 46938U_SUPELCO; H2malo |
C3H4O4 |
104.06 g/mol |
C(C(=O)O)C(=O)O |
TCMBANKIN058556 |
punicafolin |
|
C41H30O26 |
938.66 |
C1C2C(C(C(C(O2)OC(=O)C3=CC(=C(C(=C3)O)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O)OC(=O)C5=CC(=C(C(=C5C6=C(C(=C(C=C6C(=O)O1)O)O)O)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O |
TCMBANKIN060264 |
rutin |
|
C27H30O16 |
610.5 g/mol |
CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O |
TCMBANKIN061544 |
cuscutin |
bergenin;3,4,4a,10b-Tetrahydro-3,4,8,10-tetrahydroxy-2-(hydroxymethyl)-9-methoxypyrano(3,2-c)(2)benzopyran-6(H)-one; D01040; Bergenin [JAN]; 477-90-7 (ANYDROUS); Bergenin; Bergenin (JAN); Pyrano[3,2-c][2]benzopyran-6(2H)-one, 3,4,4a,10b-tetrahydro-3,4,8,10-tetrahydroxy-2-(hydroxymethyl)-9-methoxy-, (2R,3S,4S,4aR,10bS)-; CHEMBL1512567; AIDS-031337; HMS2268E16; 3,4,8,10-Tetrahydroxy-2-(hydroxymethyl)-9-methoxy-3,4,4a,10b-tetrahydropyrano[3,2-c]isochromen-6(2H)-one; (2R,3S,4S,4aR,10bS)-3,4,8,10-tetrahydroxy-9-methoxy-2-methylol-3,4,4a,10b-tetrahydro-2H-pyrano[3,2-c]isochromen-6-one; MLS000563027; 4-Methoxy-2-(tetrahydro-3,4,5-trihydroxy-6-(hydroxymethyl)pyran-2-yl)alpha-resorcylic acid gamma lactone; bergenin ; BB_NC-1749; ZINC04046820; SMR001215803; C09919; 477-90-7; (2R,3S,4S,4aR,10bS)-3,4,8,10-tetrahydroxy-2-(hydroxymethyl)-9-methoxy-3,4,4a,10b-tetrahydro-2H-pyrano[3,2-c]isochromen-6-one; AIDS031337 |
C14H16O9 |
328.27 g/mol |
COC1=C(C=C2C(=C1O)C3C(C(C(C(O3)CO)O)O)OC2=O)O |